A new clinical trial suggests that changing when you eat could make a meaningful difference for people living with Crohn’s disease. Researchers found that time-restricted feeding, a form of intermittent fasting that limits meals to an 8-hour daily window, reduced disease activity by 40% and cut abdominal discomfort in half over 12 weeks. Participants also lost weight and showed healthier inflammation and immune markers, even though they did not reduce calories or change what they ate.
AI Startup Red Queen Bio Uses Artificial Intelligence to Prepare for a Future Pandemic
Red Queen Bio is using AI to design antibody drugs against novel pathogens, highlighting the growing role of artificial intelligence in pandemic preparedness and biotech.


0 Comments